Knobil Katharine — SEC Form 4 filings

SEC reporting owner CIK 1768011. 7 Form 4 filings on record with FilingPulse; latest filed 2026-06-11.

Transaction summary — filings shown

Covers all 7 filings on record, filed 2024-06-17 to 2026-06-11. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Korro Bio, Inc. (KRRO)Director33
Marker Therapeutics, Inc. (MRKR)Director23
PLIANT THERAPEUTICS, INC. (PLRX)Director22

Form 4 filings — Knobil Katharine

FiledFormIssuerReported transactionsSource
2026-06-114Korro Bio, Inc. (KRRO)Grant/award (A): 14,677 (derivative) @ $0EDGAR
2025-11-194Marker Therapeutics, Inc. (MRKR)Grant/award (A): 84,411 (derivative) @ $0 · Grant/award (A): 137,330 (derivative) @ $0EDGAR
2025-06-124Korro Bio, Inc. (KRRO)Grant/award (A): 6,010 (derivative) @ $0EDGAR
2025-06-094PLIANT THERAPEUTICS, INC. (PLRX)Grant/award (A): 30,000 (derivative) @ $0EDGAR
2025-02-144Marker Therapeutics, Inc. (MRKR)Grant/award (A): 30,000 (derivative) @ $0EDGAR
2024-08-284Korro Bio, Inc. (KRRO)Grant/award (A): 9,041 (derivative) @ $0EDGAR
2024-06-174PLIANT THERAPEUTICS, INC. (PLRX)Grant/award (A): 26,764 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1768011 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →